Reports
Reports
Sale
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Artificial Pancreas Device Systems Market Overview
3.1 Global Artificial Pancreas Device Systems Market Historical Value (2017-2023)
3.2 Global Artificial Pancreas Device Systems Market Forecast Value (2024-2032)
4 Global Artificial Pancreas Device Systems Market Landscape*
4.1 Global Artificial Pancreas Device Systems Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Artificial Pancreas Device Systems Market: Product Landscape
4.2.1 Analysis by Device Type
5 Global Artificial Pancreas Device Systems Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Artificial Pancreas Device Systems Market Segmentation (2017-2032)
6.1 Global Artificial Pancreas Device Systems Market (2017-2032) by Device Type
6.1.1 Market Overview
6.1.2 Threshold Suspend Device Systems
6.1.3 Control-to-Range (CTR) Systems
6.1.4 Control-to-Target (CTT) Systems
6.2 Global Artificial Pancreas Device Systems Market (2017-2032) by End User
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Global Artificial Pancreas Device Systems Market (2017-2032) by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Artificial Pancreas Device Systems Market (2017-2032)
7.1 North America Artificial Pancreas Device Systems Market (2017-2032) by Device Type
7.1.1 Market Overview
7.1.2 Threshold Suspend Device Systems
7.1.3 Control-to-Range (CTR) Systems
7.1.4 Control-to-Target (CTT) Systems
7.2 North America Artificial Pancreas Device Systems Market (2017-2032) by End User
7.2.1 Hospitals
7.2.2 Clinics
7.2.3 Others
7.3 North America Artificial Pancreas Device Systems Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Artificial Pancreas Device Systems Market (2017-2032)
8.1 Europe Artificial Pancreas Device Systems Market (2017-2032) by Device Type
8.1.1 Market Overview
8.1.2 Threshold Suspend Device Systems
8.1.3 Control-to-Range (CTR) Systems
8.1.4 Control-to-Target (CTT) Systems
8.2 Europe Artificial Pancreas Device Systems Market (2017-2032) by End User
8.2.1 Hospitals
8.2.2 Clinics
8.2.3 Others
8.3 Europe Artificial Pancreas Device Systems Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Artificial Pancreas Device Systems Market (2017-2032)
9.1 Asia Pacific Artificial Pancreas Device Systems Market (2017-2032) by Device Type
9.1.1 Market Overview
9.1.2 Threshold Suspend Device Systems
9.1.3 Control-to-Range (CTR) Systems
9.1.4 Control-to-Target (CTT) Systems
9.2 Asia Pacific Artificial Pancreas Device Systems Market (2017-2032) by End User
9.2.1 Hospitals
9.2.2 Clinics
9.2.3 Others
9.3 Asia Pacific Artificial Pancreas Device Systems Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Artificial Pancreas Device Systems Market (2017-2032)
10.1 Latin America Artificial Pancreas Device Systems Market (2017-2032) by Device Type
10.1.1 Market Overview
10.1.2 Threshold Suspend Device Systems
10.1.3 Control-to-Range (CTR) Systems
10.1.4 Control-to-Target (CTT) Systems
10.2 Latin America Artificial Pancreas Device Systems Market (2017-2032) by End User
10.2.1 Hospitals
10.2.2 Clinics
10.2.3 Others
10.3 Latin America Artificial Pancreas Device Systems Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Artificial Pancreas Device Systems Market (2017-2032)
11.1 Middle East and Africa Artificial Pancreas Device Systems Market (2017-2032) by Device Type
11.1.1 Market Overview
11.1.2 Threshold Suspend Device Systems
11.1.3 Control-to-Range (CTR) Systems
11.1.4 Control-to-Target (CTT) Systems
11.2 Middle East and Africa Artificial Pancreas Device Systems Market (2017-2032) by End User
11.2.1 Hospitals
11.2.2 Clinics
11.2.3 Others
11.3 Middle East and Africa Artificial Pancreas Device Systems Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Component of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Product
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Component of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Component of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Market Share by Top 5 Companies
17.2 Medtronic
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 EOFLOW CO., LTD
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Beta Bionics
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Tandem Diabetes Care, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Insulet Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Dexcom
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Medtrum Technologies Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Nikkiso Co., Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Pancreum, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Abbott
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Admetsys Corporation
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 INREDA® DIABETIC B.V.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Diabeloop SA
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
18 Global Artificial Pancreas Device Systems Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.